Nucleic Acid Test Kits for Pets Market to Reach USD 443.0 Million by 2035 with Rising Demand for Preventive Care

The global pet diagnostics landscape is entering a new era, where technology, compassion, and science converge to redefine animal healthcare. According to the latest report, the nucleic acid test kits for pets market is projected to expand from USD 207.1 million in 2025 to USD 443.0 million by 2035, reflecting a 7.9% CAGR. This remarkable growth mirrors rising pet ownership, increasing emphasis on preventive veterinary care, and breakthroughs in genetic and molecular testing platforms.

Growing Significance of Pet Health Diagnostics

The past decade has seen the rise of "pet humanization," where animals are embraced as family members. This cultural shift is driving investments into advanced healthcare for companion animals. Pet parents today want more than routine veterinary visits-they seek insights into their pets' genetic backgrounds, predisposition to diseases, and tailored health recommendations. Nucleic acid test kits are emerging as the key bridge between personalized pet healthcare and scientific innovation, offering accurate, fast, and reliable results.

In 2025 alone, PCR-based kits will account for over 52% of the market share, reinforcing their position as the gold standard for veterinary molecular testing. Dogs, representing 58% of applications, dominate demand due to their population size, genetic diversity, and owner willingness to invest in preventive diagnostics.

Market Dynamics and Growth Phases

Year-on-year analysis shows steady expansion, with revenues expected to climb to USD 223.5 million by 2026 and USD 260.2 million by 2028. Early growth stems from widespread adoption of testing in veterinary hospitals and clinics, where rapid, accurate diagnostics are essential for disease prevention.

From 2029 to 2032, the market is expected to reach USD 352.7 million, with nearly 40% of cumulative growth generated in this period. This acceleration is fueled by rising disposable incomes, genetic disease awareness, and the spread of diagnostic infrastructure in emerging economies. By 2035, the market achieves USD 443.0 million, propelled by innovations in at-home test kits, point-of-care diagnostics, and integration with digital veterinary platforms.

Why the Market is Expanding

The strength of this market lies in the convergence of veterinary genomics and consumer demand. Sophisticated yet accessible diagnostic platforms are empowering pet owners to manage their animals' health proactively. These tests go beyond breed identification-they uncover genetic predispositions, support preventive care, and improve the quality of life for millions of companion animals worldwide.

Pet wellness has transformed from a reactive practice into a preventive, data-driven healthcare model. This transition is evident in the adoption of DNA and RNA testing systems, which not only support clinical decision-making for veterinarians but also give owners actionable insights into diet, exercise, and medical care tailored to their pets' unique profiles.

Regional Outlook

Global growth is not uniform, but rather shaped by regional dynamics.

China leads with an expected 10.7% CAGR, thanks to rising pet ownership and rapid urbanization. Over 450,000 kits were sold in 2024, demonstrating the strong demand for genetic testing in veterinary settings.
India, at 9.9% CAGR, follows closely with increasing awareness and expanding veterinary networks in urban and semi-urban regions.
Germany (9.1% CAGR) showcases the strength of Europe's veterinary healthcare infrastructure, supported by government-backed animal research.
Brazil (8.3% CAGR) is emerging as a significant market with rising exotic pet ownership and robust veterinary investments.
The United States remains a mature yet innovative market with 7.5% CAGR, driven by premium testing applications, tele-veterinary integration, and strong research pipelines.
The United Kingdom and Japan show steady growth, underscoring the influence of established veterinary standards and precision healthcare.

In Europe, Germany, the UK, and France together dominate regional demand, while Italy and Spain are accelerating adoption through growing companion animal care.

Key Industry Players Driving Innovation

The market's future is shaped by established diagnostic leaders and nimble new entrants who are innovating for accessibility and accuracy. Companies such as Flashtest, Basepaws Inc, Ustar Biotechnologies, Orivet, Embark Veterinary, Inc., Ancestry, Wisdom Panel, DNA My Dog, AlphaDog DNA, Kyodo International, Inc., Life real, Rocgene, Hfbiotech, and Shenzhen Gangzhu Medical Technology Co., Ltd. are pushing boundaries in veterinary diagnostics.

Each brings unique expertise: Embark Veterinary specializes in comprehensive canine genetic testing, Basepaws leads feline DNA diagnostics, while Wisdom Panel and Orivet expand access to global pet owners with detailed health and breed identification panels. Emerging firms like Rocgene and Hfbiotech are developing cost-efficient kits targeting rapid disease detection in diverse companion animals.

Challenges and Opportunities

Despite the promising trajectory, challenges remain. The cost of advanced genetic testing can be prohibitive for routine veterinary visits, and results often require professional interpretation. Breed-specific databases also need continuous expansion to ensure comprehensive coverage across species. However, these barriers are being addressed through consumer-friendly platforms, simplified sampling methods, and broader genomic datasets.

At the same time, opportunities are flourishing. Personalized veterinary medicine, rapid point-of-care testing, and integration of AI-driven analysis are set to redefine standards of pet care. With the rise of e-commerce in veterinary products, kits are also becoming more widely accessible to consumers worldwide.

Purchase this Report for USD 5,000 Only | Get an Exclusive Discount Instantly! https://www.futuremarketinsights.com/checkout/26658

Everything You Need-within Your Budget. Request a Special Price Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-26658

Browse the Complete Report: https://www.futuremarketinsights.com/reports/nucleic-acid-test-kits-for-pets-market

Related Reports:

Dermatology Cryosurgery Units Market: https://www.futuremarketinsights.com/reports/dermatology-cryosurgery-units-market

Dehydration Monitoring Systems Market: https://www.futuremarketinsights.com/reports/dehydration-monitoring-systems-market

Electromyography Devices Market: https://www.futuremarketinsights.com/reports/electromyography-devices-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.